Drug
Olomorasib
Olomorasib: highest development phase Phase 3, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Olomorasib NCT06890598 | Phase 3 | Carcinoma, Non-Small-Cell Lung |
Latest
No recent events.
Follow Olomorasib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.